Editor: Ali Rastegari

Nanoscience Applications in Diabetes Treatment

eBook: US $39 Special Offer (PDF + Printed Copy): US $67
Printed Copy: US $47
Library License: US $156
ISBN: 978-981-5196-54-2 (Print)
ISBN: 978-981-5196-53-5 (Online)
Year of Publication: 2023
DOI: 10.2174/9789815196535123010002


Nanotechnology has shown immense promise for advancing blood glucose control. This technology offers the potential to safeguard pancreatic cells from autoimmune destruction by driving the creation of innovative therapeutic agents that can be delivered to specific targets.

In this book, you will find a comprehensive exploration of diabetes and its approved medical treatments. The book delves into how nanotechnology can amplify the efficacy of current treatment modalities, potentially paving the way for a gene therapy solution to combat this disease. Starting with the history of diabetes treatment, the book explains treatment challenges for diabetes before getting into the three ways nanoscience is helping in diabetes treatment: insulin delivery, drug delivery and nucleotide delivery. Each chapter is contributed by accomplished experts in their respective fields, who strive to offer a thorough, yet accessible discussion of the subject.


The book is structured in a manner that sequentially covers various aspects related to diabetes and the application of nanotechnology in its treatment. Chapters 1 and 2 extensively delve into the pathophysiology of diabetes, encompassing different types of the disease, and provide an overview of the diverse medical therapy approaches available for each type. Chapter 3 focuses on the utilization of nanomedicine for insulin delivery in diabetes treatment. It thoroughly explores the various nano-based vehicles that hold the potential for delivering insulin effectively. In Chapter 4, the book extensively discusses the potential of nanoscience in drug delivery for diabetes. This chapter presents a comprehensive review of different studies that have investigated the use of nanoparticles as carriers for drug delivery in diabetes treatment. The final chapter concentrates on nanotechnology approaches for nucleotide delivery and gene therapy in diabetes. It not only highlights the advancements in this field but also addresses the associated challenges and potential future developments. Overall, the book aims to provide a comprehensive understanding of diabetes, current medical therapies, and how nanotechnology can be harnessed to enhance treatment options, including insulin delivery, drug delivery, and gene therapy.

Ali Rastegari
Department of Pharmaceutics and Pharmaceutical Nanotechnology
School of Pharmacy, Iran University of Medical Sciences
Tehran, Iran